Gu Sherry Xuejun

Executive

HK·HKEX

WuXi Biologics (Cayman) Inc.

Total declarations

Company

▲ Purchases (1 ops.)

—

▼ Sales (1 ops.)

€145k

Latest filing published 28 Aug 2026 for WuXi Biologics (Cayman) Inc..

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

WuXi Biologics (Cayman) Inc. 1 purchase · last 31 Mar 2026

Since each purchase

WuXi Biologics (Cayman) Inc.
Filed 31 Mar 2026 · 207 days ago
+58.9%
Entry HK$34.86 · Close 05 Oct 2026 HK$55.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Gu Sherry Xuejun: trading record in brief

Gu Sherry Xuejun, listed as chief executive, appears in our data through filings on WuXi Biologics (Cayman) Inc. shares, published by HKEX. We count 11 filings; the first trade dates from 10 June 2025 and the latest from 24 August 2026.

Market trades split into 1 purchase and 1 sale (€145k). The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 1 purchase and no sales.

The newest entry dates from 28 August 2026: a transaction, in WuXi Biologics (Cayman) Inc. The clock since the last published purchase (31 March 2026) now reads 207 days. The median gap between a trade and its publication by HKEX is 5 days. That lag is the time during which only the insider knows about the trade. This summary is built from HKEX disclosures alone and does not predict where the share price will go.